Literature DB >> 2248634

Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota.

S J Phillips1, J P Whisnant, W M O'Fallon, R L Frye.   

Abstract

To determine the prevalence of cardiac disorders as risk factors for stroke, we conducted a survey in 1986 in a stratified random sample of the population of Rochester, Minnesota, 35 years of age or older. The medical records of the 2,122 subjects in the sample were retrieved with use of the Rochester Epidemiology Project medical records linkage system. The data were used to estimate (1) the reliability of self-reported information about cardiac and cerebrovascular disorders and (2) the age- and sex-specific prevalence of diabetes mellitus and various cardiac and cerebrovascular conditions. The estimated prevalence for selected risk factors in the population 35 years of age or older was 5.8% for diabetes mellitus, 3.3% for myocardial infarction, 1.2% for mitral valve disease, 4.2% for left ventricular hypertrophy, and 2.8% for atrial fibrillation or flutter. These data can be used to estimate resources required for evaluation and management of the disorders. When the prevalence and the relative risk for stroke are known for a particular cardiac disorder, the proportion of stroke attributable to that disorder can be estimated.

Entities:  

Mesh:

Year:  1990        PMID: 2248634     DOI: 10.1016/s0025-6196(12)62535-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  15 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

2.  Epidemiological burden of heart failure.

Authors:  L Tavazzi
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 3.  Atrial fibrillation and heart failure in the elderly.

Authors:  Pedram Kazemian; Gavin Oudit; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 4.  Management of atrial fibrillation: out-of-hospital approach.

Authors:  E D Folland
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

5.  Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent.

Authors:  Luciana S Fornari; Daniela Calderaro; Ivana B Nassar; Cristiane Lauretti; Lidia Nakamura; Renato Bagnatori; Walter Ageno; Bruno Caramelli
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

6.  Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study.

Authors:  Charles B Upshaw
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

7.  Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.

Authors:  Jonathan N Johnson; David J Tester; James Perry; Benjamin A Salisbury; Carol R Reed; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2008-02-08       Impact factor: 6.343

8.  Risk factors for heart failure: a population-based case-control study.

Authors:  Shannon M Dunlay; Susan A Weston; Steven J Jacobsen; Véronique L Roger
Journal:  Am J Med       Date:  2009-11       Impact factor: 4.965

Review 9.  Epidemiology of arrhythmias and conduction disorders in older adults.

Authors:  Grant V Chow; Joseph E Marine; Jerome L Fleg
Journal:  Clin Geriatr Med       Date:  2012-11       Impact factor: 3.076

Review 10.  Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.

Authors:  Gerald V Naccarelli; Frank Peacock
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.